Why the Sign Needs Context
An additive delta is a numerical shift applied to the reference distribution for missing outcomes in a pattern-mixture sensitivity analysis. The sign tells you whether the shifted values are numerically higher or lower than that reference. It does not, by itself, say whether the assumption is favorable, unfavorable, optimistic, or pessimistic. That clinical interpretation depends on what the outcome measures and how it is coded.
For example, a positive shift in systolic blood pressure increases the assumed blood pressure, which is usually less favorable when lower blood pressure is the desired outcome. A positive shift in symptom-free days increases a measure for which higher values are usually favorable. The same sign can therefore describe different clinical directions across outcomes.
The sign convention is defined on the numerical scale, not on a universal scale of clinical desirability. Before calling a delta assumption favorable or unfavorable, state whether higher or lower outcome values are desirable. Also state which treatment arm and missing-outcome group the assumed shift concerns; a delta describes an assumption about missing values, not a change to outcomes that were observed.
What the Shift Does to a Group Mean
Suppose a group has \(n\) participants, of whom \(m\) have a missing endpoint. Keep the observed outcomes fixed. If the MAR reference mean among the missing participants is \(\bar{Y}^{\mathrm{MAR}}_{\mathrm{mis}}\), applying a common additive delta gives a missing-group mean of \(\bar{Y}^{\mathrm{MAR}}_{\mathrm{mis}}+\delta\). The full-group mean changes by \(m\delta/n\), not by \(\delta\), because only the missing fraction receives the shift.
This identity follows by writing each full-group mean as the sum of the fixed observed-outcome total and the imputed missing-outcome total, divided by \(n\). The adjusted missing total is \(m(\bar{Y}^{\mathrm{MAR}}_{\mathrm{mis}}+\delta)\), which exceeds the MAR missing total by \(m\delta\). Dividing that difference by \(n\) gives the displayed result. It is an arithmetic consequence of the common shift; it does not establish that a particular delta is clinically plausible.
Worked Example: Positive Delta for an Unfavorable-Higher Outcome
Consider a hypothetical treatment group with systolic blood pressure as the endpoint, measured in mmHg; lower values are considered more favorable. Of 50 participants, 40 have observed blood pressure with mean 130 mmHg. For the 10 participants with missing endpoints, suppose the MAR reference mean is 132 mmHg. Examine a positive delta of \(+4\) mmHg.
The adjusted reference mean for the missing group is \(132+4=136\) mmHg. The delta is positive because this assumption raises the missing values numerically. Since higher blood pressure is less favorable in this example, the assumption is clinically less favorable for the treatment group than its MAR reference.
Under MAR, the full-group mean is \(\{40(130)+10(132)\}/50=(5200+1320)/50=6520/50=130.4\) mmHg.
Under the adjusted assumption, the full-group mean is \(\{40(130)+10(136)\}/50=(5200+1360)/50=6560/50=131.2\) mmHg. The increase is \(131.2-130.4=0.8\) mmHg, also equal to the missing fraction times the delta: \((10/50)(4)=0.8\) mmHg.
For context, suppose a hypothetical control-group mean is 134 mmHg and is unchanged in this sensitivity scenario. The treatment-minus-control difference is \(130.4-134=-3.6\) mmHg under MAR and \(131.2-134=-2.8\) mmHg under the adjustment. Negative differences favor treatment when lower blood pressure is better. The positive delta makes the estimated advantage smaller in magnitude, from 3.6 to 2.8 mmHg; it does not reverse the direction in these values.
When Higher Values Are Favorable
For an endpoint such as symptom-free days, it may be more favorable to have a higher value. A negative delta then lowers the missing outcomes relative to MAR and is a less favorable assumption for that group. It remains a negative numerical shift; the clinical label follows from the endpoint's meaning.
Worked Example: Negative Delta for a Favorable-Higher Outcome
In a hypothetical group, symptom-free days over a fixed period is the endpoint, and more days are considered better. There are 40 participants: 30 with observed outcomes averaging 8 days and 10 with missing outcomes whose MAR reference mean is 7 days. Examine \(\delta=-2\) days for the missing outcomes.
The adjusted missing-outcome mean is \(7+(-2)=5\) days. The negative delta lowers the numerical value by 2 days, so in this setting it represents a less favorable assumption than the MAR reference.
The MAR full-group mean is \(\{30(8)+10(7)\}/40=(240+70)/40=310/40=7.75\) days. The adjusted full-group mean is \(\{30(8)+10(5)\}/40=(240+50)/40=290/40=7.25\) days. The change is \(7.25-7.75=-0.50\) days, which agrees with \((10/40)(-2)=-0.50\) days.
The 2-day shift applies to the missing-group reference mean, while the full-group average falls by only 0.50 days because one quarter of participants have missing outcomes. Calling the assumption unfavorable here depends on the explicit fact that more symptom-free days are better.
Sign Changes When Outcome Coding Changes
Clinical records can describe the same underlying condition using differently oriented scales. Suppose one scale records symptom severity, so higher values mean worse symptoms, and another records symptom relief, so higher values mean greater relief. A shift that worsens symptoms has opposite numerical signs on these two scales. Sign interpretation must therefore start with the recorded endpoint, not with a verbal label such as “worse.”
Worked Example: Reversing the Outcome Scale
Suppose a hypothetical symptom-severity score ranges from 0 to 10, where higher scores mean worse symptoms. There are 75 participants, 60 with observed scores averaging 4.5 and 15 with missing scores whose MAR reference mean is 6. Examine a severity-scale delta of \(-1\) point.
The adjusted missing severity mean is \(6-1=5\) points, a numerical decrease and, because lower severity is better, a more favorable assumption. The full-group MAR mean is \(\{60(4.5)+15(6)\}/75=(270+90)/75=360/75=4.8\) points. The adjusted full-group mean is \(\{60(4.5)+15(5)\}/75=(270+75)/75=345/75=4.6\) points. The full-group change is \(4.6-4.8=-0.2\) points, equal to \((15/75)(-1)=-0.2\) points.
Now define a relief score as \(10-\text{severity}\), so higher relief is better. A severity decrease of 1 point corresponds to a relief increase of 1 point: the same assumption would be represented by a delta of \(+1\) point on the relief scale. The sign changed because the outcome was recoded, not because the underlying clinical assumption changed. The two scales also have different numerical values, so their reference distributions must be expressed on their own scales.
Assumptions, Checks, and Common Errors
A delta analysis is a sensitivity analysis: observed outcomes and the reference model are held fixed while the analyst examines alternative assumptions for outcomes that are missing. The chosen delta is not generally identified from observed data alone. Interpreting it correctly therefore requires the following conditions and checks:
- State the direction of the endpoint. Specify what a larger recorded value means and which direction is clinically preferred. This is essential before labeling a delta assumption favorable or unfavorable.
- Apply the shift only where intended. The additive adjustment changes the reference values for the specified missing outcomes. It does not alter observed outcomes or automatically apply to every treatment group.
- Keep units consistent. A delta in mmHg must be added to a blood-pressure reference in mmHg; a delta in days must be added to a reference in days. Its magnitude should be interpreted on that endpoint's scale.
- Check the reference and adjusted values. Compare their ranges and summaries with plausible values for the endpoint. Even a correctly signed shift can produce implausible values if its size is unsuitable.
- Check the estimand's contrast direction. If the reported contrast is treatment minus control, determine which sign favors treatment for that endpoint. A positive delta increases the treatment-minus-control contrast if applied to treatment and decreases it if applied to control. Whether that numerical movement favors treatment depends on the endpoint direction.
For a treatment-minus-control contrast, if only the treatment group's missing outcomes receive a common delta and its missing fraction is \(m_T/n_T\), the contrast changes by \((m_T/n_T)\delta\), with the control group held fixed. If only the control group's missing outcomes receive the delta, the contrast changes by \(-(m_C/n_C)\delta\). These signs follow by subtracting the control mean from the treatment mean. They are not universal benefit signs: whether a larger contrast favors treatment still depends on whether higher values are desirable.
A frequent mistake is to say “positive delta means worse outcomes.” That is wrong as a general rule: positive delta means higher numerical values than the reference. The correction is to name the endpoint orientation. For blood pressure where lower is preferred, a positive delta shifts toward less favorable values; for symptom-free days where higher is preferred, it shifts toward more favorable values.
Another mistake is to describe a delta as though it were estimated from the observed outcomes or as though it changed the observed data. The sensitivity parameter specifies an assumption about missing outcomes relative to a reference distribution. Since multiple values may be compatible with the observed data, results across a justified range of deltas show how conclusions depend on those unobserved-outcome assumptions; they do not prove which delta is true.
The main alternative for this particular reference is the MAR analysis, represented by \(\delta=0\). It supplies a clear comparison point, but does not establish that missing outcomes actually follow the MAR reference. Reference-based imputation uses a different specified reference for missing outcomes; a delta adjustment instead expresses departure from its chosen MAR reference through a numerical shift. Neither sign nor direction can be compared meaningfully without identifying the outcome scale and the reference being shifted.
An additive shift also has limitations. Its clinical interpretation depends on the scale, and a common shift may be an oversimplification if the plausible departure differs across people or circumstances. For a bounded outcome, shifting values can create values outside the permitted range unless the model or implementation addresses that problem. Inspect the adjusted distribution, not only its mean, and do not infer plausibility from a favorable or unfavorable sign alone.
State the endpoint, its units, which outcomes are missing, and the MAR reference distribution being shifted.
A positive delta raises missing reference values; a negative delta lowers them; zero leaves them unchanged.
Use the endpoint's coding to decide whether the numerical shift is more or less favorable, then check the resulting group mean and treatment contrast.
Check Your Understanding
Answer each question by distinguishing numerical direction from clinical interpretation. Solutions follow the questions.
- A clinical endpoint is pain intensity, where higher scores indicate more pain. What does \(\delta=+1.5\) points mean numerically, and is it favorable or unfavorable?
- For an endpoint where higher values are favorable, 25% of a group has missing outcomes. What is the change in the full-group mean from a delta of \(-4\) units, assuming the other outcomes remain fixed?
- A trial reports treatment minus control for an endpoint where lower values are better. If only treatment's missing outcomes receive a positive delta, in which numerical direction does the contrast move?
- Why can the same clinical assumption have opposite delta signs on two differently coded scales?
- Does a positive delta mean that the missing outcomes are known to be worse than observed outcomes? Explain.
Solutions. (1) The missing reference values are raised by 1.5 pain-intensity points. Because higher pain is worse, this is an unfavorable direction. (2) The full-group mean changes by the missing fraction times delta: \(0.25(-4)=-1\) unit. The group mean decreases by 1 unit; whether that is favorable follows here from higher being better, so it is less favorable. (3) The treatment mean rises while the control mean is fixed, so treatment minus control increases numerically. Since lower values are better, this moves the contrast in a less favorable direction for treatment. (4) Reversing the scale reverses numerical direction: an increase in severity corresponds to a decrease in a relief score coded so higher means greater relief. (5) No. The delta states an assumed shift relative to the specified MAR reference for missing outcomes. It is a sensitivity assumption, not evidence that those unobserved outcomes are known or that they must be worse than observed outcomes.